BRCA2 c.193_195delinsTTT ;(p.P65F)

Variant ID: 13-32893339-CCA-TTT

NM_000059.3(BRCA2):c.193_195delinsTTT;(p.P65F)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells.

Breast Cancer Research : Bcr
Vazquez-Ortiz, Guelaguetza G; Chisholm, Cristine C; Xu, Xiaoling X; Lahusen, Tyler J TJ; Li, Cuiling C; Sakamuru, Srilatha S; Huang, Ruili R; Thomas, Craig J CJ; Xia, Menghang M; Deng, Chuxia C
Publication Date: 2014-06-24

Variant appearance in text: BRCA2: p65F
PubMed Link: 24962108
Variant Present in the following documents:
  • Main text
  • bcr3682.pdf
View BVdb publication page